Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.37/Share

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.37), versus ($0.51) reported last year.

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• KeyBanc Sees 'A Potential Catalyst for Earnings Growth and Value Creation' for Acadia Realty Trust (AKR)
• Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance